Vaderis exits stealth as ex-Almac Discovery candidate enters clinical development
The clinical-stage biotechnology company is working on the advancement of a treatment for a blood vessel disorder that it licensed from the other company
The clinical-stage biotechnology company is working on the advancement of a treatment for a blood vessel disorder that it licensed from the other company
The pharma company’s collaboration with the drug discovery specialist involves using artificial intelligence to discover and develop up to five drug targets.
The companies will work together to help clients connect information sources, giving stakeholders a better overview of the clinical patient experience.